20 results
8-K
EX-99.1
CTLT
Catalent, Inc.
8 May 24
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
4:20pm
service for the benefit of customers and patients. Catalent is a patient-first organization with a mission to develop, manufacture and supply products
DEFA14A
CTLT
Catalent, Inc.
5 Feb 24
Additional proxy soliciting materials
5:22pm
. Following the closing of the transaction, Catalent will become a private company and will continue to focus on our mission and our success in delivering … with Novo Holdings is in the best interest of Catalent. This announcement is a testament to our team’s hard work and dedication to our mission. In fact
DEFA14A
CTLT
Catalent, Inc.
5 Feb 24
Additional proxy soliciting materials
7:03am
. This transaction is a testament to our team’s hard work and dedication to this mission, and I am incredibly excited for this next step in our journey … mission to develop, manufacture and supply products that help people live better and healthier lives. With our expertise and track record
8-K
EX-99.1
CTLT
Catalent, Inc.
5 Feb 24
Novo Holdings to Acquire Catalent
7:00am
and dedication to this mission, and I am incredibly excited for this next step in our journey. We look forward to benefiting from Novo Holdings’ significant … are excited to partner with Catalent as it enters a new phase of growth and accelerates its mission to develop, manufacture and supply products that help
DEFA14A
meccuktuoz5wg4fb
29 Aug 23
Additional proxy soliciting materials
4:52pm
8-K
EX-99.1
8ls416shx
19 Dec 22
Catalent Announces Changes to its Board of Directors
8:14am
8-K
EX-99.2
4rtlmg0k
30 Aug 21
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
7:15am
8-K
EX-99.1
o94xezj1s
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
SC TO-C
EX-99.1
170n ybvg8jecjrx
3 Jul 18
Information about tender offer
4:52pm
- Prev
- 1
- Next